NCT01033747View on ClinicalTrials.gov

Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Liver Iron Overload
Interventions
DRUG

Deferasirox

10 mg/kg or 30 mg/kg orally daily

DRUG

Deferasirox

5 mg/kg or 30 mg/kg orally daily

Trial Locations (4)

Unknown

Novartis Investigative Site, Cagliari

Novartis Investigative Site, Genova

Novartis Investigative Site, Milan

Novartis Investigative Site, Torino

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY